Neurogenic inflammation: With additional discussion of central and perceptual integration of nonneurogenic inflammation

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 2, 1997, Pages 531-537

  Bascom, Rebecca ^a,i   Meggs, William J ^b   Frampton, Mark ^c   Hudnell, Kenneth ^d   Killburn, Kaye ^e   Kobal, Gerd ^f   Medinsky, Michelle ^g   Rea, William ^h  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^h Environmental Health Center   (United States)

ⁱ NONE   (United States)

Author keywords

Chemical sensitivity; Inflammation; Neurogenic inflammation; Perceptual and central integration

Indexed keywords

CAPSAICIN; IRRITANT AGENT; MEMBRANE METALLOENDOPEPTIDASE; NEUROPEPTIDE; PROSTANOID;

ADAPTATION; AUTONOMIC NERVOUS SYSTEM; COGNITION; CONFERENCE PAPER; HABITUATION; HUMAN; HYPOTHESIS; INFLAMMATION; MUCOSA; MULTIPLE CHEMICAL SENSITIVITY; NERVE CELL; NEUROGENIC INFLAMMATION; OLFACTORY SYSTEM; PERCEPTION; PRIORITY JOURNAL; PROVOCATION TEST; SENSORY STIMULATION; SYMPTOM; TRIGEMINAL NUCLEUS;

EID: 0030918599     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s2531     Document Type: Conference Paper

References (43)

1. Baraniuk J, Kaliner M. Neuropeptides and nasal secretion. J Allergy Clin Immunol 86:620-627 (1990).
2. Lundberg JM, Saria A. Capsaicin-sensitive vagal neurons involved in control of vascular permeability in rat trachea. Acta Physiol Scand 115:521-523 (1982).
3. Lundberg JM, Saria A, Lundblad L, Anggard A, Martling C-R, Theodorsson-Norheim E, Stjarne P, Hokfelt T. Bioactive peptides in capsaicin-sensitive c-fiber afferents of the airways: functional and pathophysiological implications. In: The Airways. Neural Control in Health and Disease (Kaliner MA, Barnes PJ, eds). New York:Marcel Dekker, 1988;417-446.
4. Barnes PJ. Neuropeptides in the lung: localization, function and pathophysiologic implication. J Allergy Clin Immunol 79:285-295 (1987).
5. Kipen H, Hallman W, Kelly-McNeil K, Fiedler N. Measuring chemical sensitivity prevalence: questionnaire for population studies. Am J Public Health 85:574-577 (1995).
6. Cullen MR. The worker with multiple chemical sensitivities: an overview. In: Workers with Multiple Chemical Sensitivities (Cullen MR, ed). Philadelphia:Hanley & Belfus, 1987;655-662.
7. National Research Council. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington:National Academy Press, 1992.
8. Benignus, VA. Commentary. Systematic considerations in the area of multiple chemical sensitivity. Environ Health Perspect 105(Suppl2):485 (1997).
9. Medinsky MA. Determinants of gas and vapor uptake in the respiratory tract. CIIT Activities 16:1-6 (1996).
10. 14C]formaldehyde in rats after inhalation exposure. In: Formaldehyde Toxicity (Gibson JE, ed). New York:Hemisphere Publishing Corporation, 1983;38-50.
11. Heck HdA, Casanova M, Starr TB. Formaldehyde toxicity -new understanding. Crit Rev Toxicol 20:397-426 (1990).
12. Miller FJ, Menzel DB, Coffin DL. Similarity between man and laboratory animals in regional pulmonary deposition of ozone. Environ Res 17:84-101 (1978).
13. Harkema JR, Plopper CG, Hyde DM, George JAS, Wilson DW, Dungworth DL. Response of macaque bronchiolar epithelium to ambient concentrations of ozone. Am J Pathol 143:857-866 (1993).
14. Harkema J, Plopper C, Hyde D, St. George A, Wilson D, Dungworth D. Response of the macaque nasal epithelium to ambient levels of ozone: a morphologic and morphometric study of transitional and respiratory epithelium. Am J Pathol 128:29-44 (1987).
15. Guerin MR, Jenkins RA, Tomkins BA. The Chemistry of Environmental Tobacco Smoke: Composition and Measurement. Chelsea, MI:Lewis Publishers, 1992.
16. Nielsen GD. Mechanisms of activation of the sensory irritant receptor by airborne chemicals. CRC Crit Rev Toxicol 21:183-208 (1991).
17. Meggs W. Neurogenic inflammation and sensitivity to environmental chemicals. Environ Health Perspect 101:234-238 (1993).
18. Dusser D, Djokic T, Borson D, Nadel J. Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. J Clin Invest 84:900-906 (1989).
19. Kobal G, Hummel T. Brain responses to chemical stimulation of trigeminal nerve in man. In: Irritation, Chemical Senses, (Breen BG, Mason JR, eds). New York:Marcel Dekker, 1989;123-139.
20. 2 in rats: is it a peripheral nociceptive event? Neurosci Lett 128:297-300 (1991).
21. Kobal G, Hummel T. Olfatory evoked potentials in humans. In: Smell and Taste in Health and Disease (Getchell TV, Doty RL, Bartoshuk LM, Snow JB Jr, eds). New York:Raven, 1991;255-275.
22. Hummel T, Kobal G. Differences in human evoked potentials related to olfactory or trigeminal chemosensory activation. Electroenceph Clin Neurophysiol 84:84-89 (1992).
23. Thurauf N, Hummel T, Kettenmann B, Kobal G. Nociceptive and reflexive responses recorded from the human nasal mucosa. Brain Res 629:293-299 (1993).
24. Hummel T, Gruber M, Pauli E, Kobal G. Chemo-somatosensory event-related potentials in response to repetitive painful chemical stimulation of the nasal mucosa. Electroenceph Clin Neurophysiol 92:426-432 (1994).
25. Hummel T, Hummel C, Friedel I, Pauli E, Kobal G. A comparison of the antinociceptive effects of imipramine, tramadol and anpirtoline. Br J Clin Pharmacol 37:325-333 (1994).
26. Hudnell H, Otto D, House D, Molhave L. Exposure of humans to a volatile organic mixture. II: Sensory. Arch Environ Health 47:31-8 (1992).
27. Hudnell HK, Otto DA, House DE. Time course of odor and irritation effects in humans exposed to a mixture of 22 volatile organic compounds. In: Proceedings of Indoor Air93 Vol 1. Helsinki:Helsinki Indoor Air93, 1993;567-572.
28. Cometto-Muniz JE, Cain WS, Hudnell HK. Human chemosensory responses to mixtures of volatile organic compounds: odor, nasal pungency, and eye irritation. Percep Psychophys (in press).
29. Kesavanathan J, Swift DL, Fitzgerald TK, Permutt T, Bascom R. Evaluation of acoustic rhinometry and posterior rhinomanometry as tools for inhalation challenge studies. J Toxicol Environ Health 48:295-308 (1996).
30. Bascom R, Kesavanathan J, Fitzgerald TK, Cheng K-H, Swift DL. Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect 103:1026-1030 (1995).
31. Doty R, Deems D, Frye R, Pelberg R, Shapiro A. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otol Head Neck Surg 114:1422-1427 (1988).
32. Bascom R, Kagey-Sobotka A, Proud D. Effect of intranasal capsaicin on symptoms and mediator release. J Pharmacol Exp Ther 259:1323-1327 (1991).
33. Bascom R, Kulle T, Kagey-Sobotka A, Proud D. Upper respiratory tract environmental tobacco smoke sensitivity. Am Rev Respir Dis 143:1304-1311 (1991).
34. Baroody F, Raford P, Willes S, Fitzgerald TK, Naclerio RM, Bascom R. The effect of ozone on the nasal methacholine (mc) in allergic and nonallergic subjects. Am Rev Respir Dis 143:A93 (1991).
35. Franck C. Eye symptoms and signs in buildings with indoor climate problems ('office eye syndrome'). Acta Ophthalmol 64:306-311 (1986).
36. Bascom R, Fitzgerald TK. A vasoconstrictor partially alters the nasal response to sidestream tobacco smoke. J Respir Crit Care Med 149:A391 (1994).
37. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis 138:406-412 (1988).
38. Baraniuk J, Castellino S, Lundgreen J, Goff J, Mullol J, Merida M, Shelhamer J, Kaliner M. Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol 3:165-173 (1990).
39. Baraniuk JN, Lundgren JD, Goff J, Mullol J, Castellino S, Merida M, Shelhamer JH, Kaliner MA. Calcitonin gene-related peptide in human nasal mucosa. Am J Physiol (Lung Mol Cell Physiol) 258:L81-L88 (1990).
40. Baraniuk J, Lundgren J, Okayama M, Mullol J, Merida M, Shelhamer J, Kaliner M. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest 86:825-831 (1990).
41. Baraniuk JN, Lundgren JD, Okayama M, Goff J, Mullol J, Merida M, Shelhamer JH, Kaliner MA. substance P and neurokinin A in human nasal mucosa. Am J Respir Cell Mol Biol 4:228-236 (1991).
42. Kehrl HR, Vincent LM, Kowalsky RJ, Horstman DH, O'Neil JJ, McCartney WH, Bromberg PA. Ozone exposure increases respiratory epithelial permeability in humans. Am Rev Respir Dis 135:1124-1128 (1987).
43. Knowles MR, Carson JL, Collier AM, Gatzy JT, Boucher RA. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis 124:484-490 (1981).